Nazlıhan Boyacı Dündar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nazlıhan Boyacı Dündar has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Gulbin Aygencel
Department of Internal Medicine, Division of Intensive Care Medicine, Gazi University School of Medicine, Ankara, Türkiye
8 shared publications - Melda Türkoğlu
Department of Internal Medicine, Division of Intensive Care Medicine, Gazi University School of Medicine, Ankara, Türkiye
8 shared publications - Kamil İnCi
Department of Internal Medicine Division of Critical Care Gazi University Faculty of Medicine Ankara Türkiye
4 shared publications - Gülendam Bozdayı
Faculty of Medicine, Medical Microbiology, Division of Virology, Gazi University
3 shared publications - Hasan Selçuk Özger
Koç University Faculty of Medicine, Department of Infectious Diseases, İstanbul, Türkiye
3 shared publications - Mehmet Yildiz
Department of Infectious Diseases and Clinical Microbiology, Karadeniz Ereğli State Hospital, Zonguldak, Turkey
3 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by MediHealth Academy in Academic Journal of Health
- Vol. 4 (2) , 49-57
Epidemiological Characteristics and Mortality of Primary Lung Cancer Patients Admitted to the Intensive Care Unit and Undergoing Invasive Mechanical Ventilation
Background and Aim: Lung cancer is a leading cause of cancer-related mortality globally. Patients frequently require intensive care unit (ICU) admission and invasive mechanical ventilation (IMV) due to disease progression, organ failure, or complications. This study aimed to characterize the demographic and clinical features, survival outcomes, and prognostic factors in patients with primary lung cancer receiving IMV. Materials and Methods: This retrospective, descriptive, cross-sectional study evaluated 84 primary lung cancer patients who were admitted to the Internal Medicine ICU of Gazi University Faculty of Medicine Hospital and received IMV between 2019 and 2024. Data regarding demographics, clinical scoring systems (APACHE II, GCS, SOFA), IMV indications, complications, and laboratory values on the day of IMV initiation were analyzed. Results: The study cohort demonstrated an exceptionally high mortality rate of 95.2%, with 80 non-survivors and 4 survivors. Clinical scoring systems (GCS, SOFA, APACHE II), as well as the timing and indications for IMV, were not significantly associated with mortality. However, sepsis/septic shock developed in 87% of patients during their ICU stay and was significantly associated with higher mortality (p=0.006). Furthermore, laboratory parameters evaluated on the day of IMV initiation revealed that higher lactate (p=0.042) and C-reactive protein (CRP) levels (p=0.024), alongside lower albumin levels (p=0.015), were statistically significantly associated with increased mortality. Conclusion: The mortality rate among primary lung cancer patients requiring IMV is markedly high. Mortality is significantly associated with critical illness-related factors, specifically the development of sepsis or septic shock, hypoalbuminemia, and elevated CRP and lactate levels. These findings highlight the importance of assessing the patient's acute systemic inflammatory and metabolic responses alongside the underlying malignancy.
- 25 August 2026
- Published by MediHealth Academy in Academic Journal of Health
- Vol. 4 (2) , 49-57
Open AccessEpidemiological Characteristics and Mortality of Primary Lung Cancer Patients Admitted to the Intensive Care Unit and Undergoing Invasive Mechanical Ventilation
Background and Aim: Lung cancer is a leading cause of cancer-related mortality globally. Patients frequently require intensive care unit (ICU) admission and invasive mechanical ventilation (IMV) due to disease progression, organ failure, or complications. This study aimed to characterize the demographic and clinical features, survival outcomes, and prognostic factors in patients with primary lung cancer receiving IMV. Materials and Methods: This retrospective, descriptive, cross-sectional study evaluated 84 primary lung cancer patients who were admitted to the Internal Medicine ICU of Gazi University Faculty of Medicine Hospital and received IMV between 2019 and 2024. Data regarding demographics, clinical scoring systems (APACHE II, GCS, SOFA), IMV indications, complications, and laboratory values on the day of IMV initiation were analyzed. Results: The study cohort demonstrated an exceptionally high mortality rate of 95.2%, with 80 non-survivors and 4 survivors. Clinical scoring systems (GCS, SOFA, APACHE II), as well as the timing and indications for IMV, were not significantly associated with mortality. However, sepsis/septic shock developed in 87% of patients during their ICU stay and was significantly associated with higher mortality (p=0.006). Furthermore, laboratory parameters evaluated on the day of IMV initiation revealed that higher lactate (p=0.042) and C-reactive protein (CRP) levels (p=0.024), alongside lower albumin levels (p=0.015), were statistically significantly associated with increased mortality. Conclusion: The mortality rate among primary lung cancer patients requiring IMV is markedly high. Mortality is significantly associated with critical illness-related factors, specifically the development of sepsis or septic shock, hypoalbuminemia, and elevated CRP and lactate levels. These findings highlight the importance of assessing the patient's acute systemic inflammatory and metabolic responses alongside the underlying malignancy.
- Open Access
- 30 July 2026
- Published by Turkish Society of Clinical Enteral and Parenteral Nutrition in Clinical Science of Nutrition
- Vol. 8 (2) , 128-136
The relationship between nutritional risk and clinical outcomes in medical patients transferred from internal medicine wards to the intensive care unit
Objective: Malnutrition is common in hospitalized medical patients but is frequently underrecognized and undertreated. This study aimed to determine the prevalence of nutritional risk at intensive care unit (ICU) admission among patients transferred from internal medicine wards of a university hospital, to evaluate nutritional interventions during hospitalization in the wards, and to investigate the association between nutritional risk and ICU outcomes. Methods: This retrospective observational study included adult patients transferred from internal medicine wards to a tertiary ICU between November 2022 and June 2025. Nutritional risk was assessed within 24 hours of ICU admission using the modified Nutrition Risk in the Critically Ill (mNUTRIC) score. Patients were categorized as high (mNUTRIC ≥5) or low (mNUTRIC <5) risk of malnutrition. Clinical characteristics, nutritional interventions before ICU admission, and ICU outcomes were compared between groups. Multivariable logistic regression analysis was performed to identify independent predictors of ICU mortality. Results: Among 340 patients, 205(60.3%) had high malnutrition risk at ICU admission. High-risk patients were older and had significantly higher APACHE II and SOFA scores. Nutritional support during hospitalization in the ward was initiated in fewer than half of patients with high malnutrition risk (46.3%). Compared with low-risk patients, those with high malnutrition risk more frequently required invasive mechanical ventilation (63.2% vs 31.9%, p<0.001), developed ICU-acquired infections (33.7% vs 20.9%, p=0.011), and experienced higher ICU mortality (56.1% vs 25.9%, p<0.001). In multivariable analysis, high nutritional risk independently predicted ICU mortality (OR 2.85, 95%CI: 1.64–4.98, p<0.001), together with RIFLE Failure stage (OR 2.36, 95% CI: 1.23–4.53, p=0.010), ICU admission due to sepsis (OR 1.84, 95% CI: 1.07–3.17, p=0.028), and hypoalbuminemia (OR 2.36, 95% CI: 1.40–3.99, p=0.001). Conclusion: These findings highlight nutritional risk as a key determinant of outcomes in patients transferred from internal medicine wards to the ICU and underscore the importance of early nutritional assessment in wards.
- 30 July 2026
- Published by Turkish Society of Clinical Enteral and Parenteral Nutrition in Clinical Science of Nutrition
- Vol. 8 (2) , 128-136
Open AccessThe relationship between nutritional risk and clinical outcomes in medical patients transferred from internal medicine wards to the intensive care unit
Objective: Malnutrition is common in hospitalized medical patients but is frequently underrecognized and undertreated. This study aimed to determine the prevalence of nutritional risk at intensive care unit (ICU) admission among patients transferred from internal medicine wards of a university hospital, to evaluate nutritional interventions during hospitalization in the wards, and to investigate the association between nutritional risk and ICU outcomes. Methods: This retrospective observational study included adult patients transferred from internal medicine wards to a tertiary ICU between November 2022 and June 2025. Nutritional risk was assessed within 24 hours of ICU admission using the modified Nutrition Risk in the Critically Ill (mNUTRIC) score. Patients were categorized as high (mNUTRIC ≥5) or low (mNUTRIC <5) risk of malnutrition. Clinical characteristics, nutritional interventions before ICU admission, and ICU outcomes were compared between groups. Multivariable logistic regression analysis was performed to identify independent predictors of ICU mortality. Results: Among 340 patients, 205(60.3%) had high malnutrition risk at ICU admission. High-risk patients were older and had significantly higher APACHE II and SOFA scores. Nutritional support during hospitalization in the ward was initiated in fewer than half of patients with high malnutrition risk (46.3%). Compared with low-risk patients, those with high malnutrition risk more frequently required invasive mechanical ventilation (63.2% vs 31.9%, p<0.001), developed ICU-acquired infections (33.7% vs 20.9%, p=0.011), and experienced higher ICU mortality (56.1% vs 25.9%, p<0.001). In multivariable analysis, high nutritional risk independently predicted ICU mortality (OR 2.85, 95%CI: 1.64–4.98, p<0.001), together with RIFLE Failure stage (OR 2.36, 95% CI: 1.23–4.53, p=0.010), ICU admission due to sepsis (OR 1.84, 95% CI: 1.07–3.17, p=0.028), and hypoalbuminemia (OR 2.36, 95% CI: 1.40–3.99, p=0.001). Conclusion: These findings highlight nutritional risk as a key determinant of outcomes in patients transferred from internal medicine wards to the ICU and underscore the importance of early nutritional assessment in wards.
- 30 September 2025
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 78 (3) , 177-186
Determinants of ICU Outcomes in Fully Active Patients Before Critical Illness
Aim: To investigate ICU outcomes and early mortality predictors in fully active patients prior to critical illness, a population often considered resilient, yet underrepresented in outcome studies. Materials and Methods: This retrospective cohort study included 139 patients admitted to the medical ICUs of a tertiary hospital between November 2022 and February 2025. Only patients with preserved pre-ICU performance status [Eastern Cooperative Oncology Group (ECOG)≤1 or Clinical Frailty Scale (CFS)≤3] were included. Demographics, comorbidities, admission diagnoses, severity scores (Acute Physiology and Chronic Health Evaluation II [APACHE-II], Sequential Organ Failure Assessment [SOFA]), interventions, and laboratory parameters were recorded. Logistic regression was used to identify the independent predictors for ICU mortality. Results: The ICU mortality rate was 16.5% in fully active critically ill patients. Non-survivors had significantly higher APACHE II and SOFA scores, abnormal laboratory findings, and a greater requirement for mechanical ventilation and renal replacement therapy. Cardiac arrest prior to admission and concominant septic shock were more frequently in non-survivors. ICU admission from inpatient wards (OR 5.69,p=0.023), cardiac arrest before ICU admission (OR 33.45,p=0.002), pulmonary disease as a comorbidity (OR 15.19,p=0.002), concomitant septic shock (OR 5.08,p=0.032), and acute kidney injury (AKI)(OR 10.02,p=0.032) were independent risk factors for ICU mortality, Moreover, SOFA and APACHE II scores showed strong discriminative ability for ICU mortality (AUCs:0.916 and 0.873). Conclusion: Although fully active before critical illness, these patients are not immune to poor ICU outcomes. Our findings highlight that specific clinical presentations like septic shock, cardiac arrest, and AKI carry substantial prognostic value, even in patients considered low-risk by baseline performance.
- 30 September 2025
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 78 (3) , 177-186
Determinants of ICU Outcomes in Fully Active Patients Before Critical Illness
Aim: To investigate ICU outcomes and early mortality predictors in fully active patients prior to critical illness, a population often considered resilient, yet underrepresented in outcome studies. Materials and Methods: This retrospective cohort study included 139 patients admitted to the medical ICUs of a tertiary hospital between November 2022 and February 2025. Only patients with preserved pre-ICU performance status [Eastern Cooperative Oncology Group (ECOG)≤1 or Clinical Frailty Scale (CFS)≤3] were included. Demographics, comorbidities, admission diagnoses, severity scores (Acute Physiology and Chronic Health Evaluation II [APACHE-II], Sequential Organ Failure Assessment [SOFA]), interventions, and laboratory parameters were recorded. Logistic regression was used to identify the independent predictors for ICU mortality. Results: The ICU mortality rate was 16.5% in fully active critically ill patients. Non-survivors had significantly higher APACHE II and SOFA scores, abnormal laboratory findings, and a greater requirement for mechanical ventilation and renal replacement therapy. Cardiac arrest prior to admission and concominant septic shock were more frequently in non-survivors. ICU admission from inpatient wards (OR 5.69,p=0.023), cardiac arrest before ICU admission (OR 33.45,p=0.002), pulmonary disease as a comorbidity (OR 15.19,p=0.002), concomitant septic shock (OR 5.08,p=0.032), and acute kidney injury (AKI)(OR 10.02,p=0.032) were independent risk factors for ICU mortality, Moreover, SOFA and APACHE II scores showed strong discriminative ability for ICU mortality (AUCs:0.916 and 0.873). Conclusion: Although fully active before critical illness, these patients are not immune to poor ICU outcomes. Our findings highlight that specific clinical presentations like septic shock, cardiac arrest, and AKI carry substantial prognostic value, even in patients considered low-risk by baseline performance.
- Open Access
- 16 June 2025
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 36 (9) , 600-608
Prognostic Value of Inflammatory Markers in Septic Critically Ill Patients with Chronic Liver Disease: A Retrospective Analysis*
Background/Aims: Septic patients with chronic liver disease (CLD) experience high morbidity and mortality rates, particularly in the intensive care unit (ICU) setting, due to immune dysfunction. Despite their vulnerability, data on prognostic markers remain scarce, particularly when assessed in conjunction with disease severity scores. This study aimed to evaluate the prognostic value of various inflammatory markers, including white blood cell count (WBC), neutrophil-to-lymphocyte ratio (NLR), lactate, and lactate-to-albumin ratio (LAR), in septic critically ill CLD patients. Materials and Methods: A retrospective cohort study was conducted on 126 septic CLD patients admitted to ICU. Data on demographics, clinical scores, inflammatory markers, and clinical outcomes were collected. Logistic regression and ROC analyses were used to identify independent predictors of ICU mortality. Results: Intensive care unit mortality was 66%. In addition to higher Acute Physiology and Chronic Health Evaluation II (APACHE II) (39.3 Å} 7.2 vs. 21 Å} 5.1, P < .001), Sequential Organ Failure Assessment (12.4 Å} 3.5 vs. 8.5 Å} 3.1, P < .001), CLIF-C ACLF [63 (54-69) vs. 50 (41-53)] scores, ICU non-survivors had higher WBC (median: 14 400/μL vs. 7300/μL, P < .001), lactate (median: 4.6mmol/L vs. 2.4mmol/L, P < .001), NLR (median: 12.5 vs. 9, P = .015), and LAR (median: 2.15 vs. 0.93, P < .001) compared to survivors. Multivariate analysis identified APACHE II (OR 1.183, 95% CI: 1.003-1.396, P = .046), CLIF-C ACLF (OR 1.104, 95% CI: 1.002-1.216, P = .046), and LAR (OR 2.992, 95% CI: 1.277-7.009, P = .012) as independent predictors of ICU mortality. The LAR was the most significant inflammatory marker (area under the curve: 0.783, cut-off: 1.17), even in the subgroup of patients with low acute decompensation scores based on the CLIF-C ACLF score. Conclusion: The LAR was a valuable prognostic marker for ICU mortality in septic CLD patients, even in the absence of advanced organ failure. This marker potentially outperforms other traditional inflammatory markers and could aid in early risk stratification for critically ill septic CLD patients. Cite this article as: Boyacı Dündar N, İnci K, Aygencel G, Türkoğlu M, G.k.e O, Cindoruk M. Prognostic Value of Inflammatory Markers in Septic Critically Ill Patients with Chronic Liver Disease: A Retrospective Analysis. Turk J Gastroenterol. 2025;36(9):600-608.
- 16 June 2025
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 36 (9) , 600-608
Open AccessPrognostic Value of Inflammatory Markers in Septic Critically Ill Patients with Chronic Liver Disease: A Retrospective Analysis*
Background/Aims: Septic patients with chronic liver disease (CLD) experience high morbidity and mortality rates, particularly in the intensive care unit (ICU) setting, due to immune dysfunction. Despite their vulnerability, data on prognostic markers remain scarce, particularly when assessed in conjunction with disease severity scores. This study aimed to evaluate the prognostic value of various inflammatory markers, including white blood cell count (WBC), neutrophil-to-lymphocyte ratio (NLR), lactate, and lactate-to-albumin ratio (LAR), in septic critically ill CLD patients. Materials and Methods: A retrospective cohort study was conducted on 126 septic CLD patients admitted to ICU. Data on demographics, clinical scores, inflammatory markers, and clinical outcomes were collected. Logistic regression and ROC analyses were used to identify independent predictors of ICU mortality. Results: Intensive care unit mortality was 66%. In addition to higher Acute Physiology and Chronic Health Evaluation II (APACHE II) (39.3 Å} 7.2 vs. 21 Å} 5.1, P < .001), Sequential Organ Failure Assessment (12.4 Å} 3.5 vs. 8.5 Å} 3.1, P < .001), CLIF-C ACLF [63 (54-69) vs. 50 (41-53)] scores, ICU non-survivors had higher WBC (median: 14 400/μL vs. 7300/μL, P < .001), lactate (median: 4.6mmol/L vs. 2.4mmol/L, P < .001), NLR (median: 12.5 vs. 9, P = .015), and LAR (median: 2.15 vs. 0.93, P < .001) compared to survivors. Multivariate analysis identified APACHE II (OR 1.183, 95% CI: 1.003-1.396, P = .046), CLIF-C ACLF (OR 1.104, 95% CI: 1.002-1.216, P = .046), and LAR (OR 2.992, 95% CI: 1.277-7.009, P = .012) as independent predictors of ICU mortality. The LAR was the most significant inflammatory marker (area under the curve: 0.783, cut-off: 1.17), even in the subgroup of patients with low acute decompensation scores based on the CLIF-C ACLF score. Conclusion: The LAR was a valuable prognostic marker for ICU mortality in septic CLD patients, even in the absence of advanced organ failure. This marker potentially outperforms other traditional inflammatory markers and could aid in early risk stratification for critically ill septic CLD patients. Cite this article as: Boyacı Dündar N, İnci K, Aygencel G, Türkoğlu M, G.k.e O, Cindoruk M. Prognostic Value of Inflammatory Markers in Septic Critically Ill Patients with Chronic Liver Disease: A Retrospective Analysis. Turk J Gastroenterol. 2025;36(9):600-608.
- Open Access
- 26 September 2024
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 6 (3) , 206-215
Changes of Procalcitonin Kinetics According to Renal Clearance in Critically Ill Patients with Primary Gram-Negative Bloodstream Infections
Procalcitonin (PCT) is a biomarker frequently used in the diagnosis and prognosis of infection. The lack of optimum cut-off values and the high serum PCT levels in some non-infectious conditions restrict its clinical use. Therefore, PCT use is not recommended regardless of clinical parameters. This limitation in clinical use has led to PCT kinetic evaluations rather than predictions
- 26 September 2024
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 6 (3) , 206-215
Open AccessChanges of Procalcitonin Kinetics According to Renal Clearance in Critically Ill Patients with Primary Gram-Negative Bloodstream Infections
Procalcitonin (PCT) is a biomarker frequently used in the diagnosis and prognosis of infection. The lack of optimum cut-off values and the high serum PCT levels in some non-infectious conditions restrict its clinical use. Therefore, PCT use is not recommended regardless of clinical parameters. This limitation in clinical use has led to PCT kinetic evaluations rather than predictions
- Open Access
- 6 October 2023
- Published by Springer Nature in Intensive Care Medicine Experimental
- Vol. 11 (1) , 1-12
Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases
Purpose: A prompt and effective immune response is required for clearance of pathogens but exaggerated states of inflammation can cause extensive collateral damage to the host. We have previously used a rapid near-patient assay that measures the functional capacity of neutrophils to produce reactive oxygen species (ROS) to show that values are elevated in patients with severe COVID-19 or sepsis. Here, we assess the utility of longitudinal ROS measurements to monitor and predict mortality outcome for patients with COVID-19 infection being treated in an ICU setting. Methods: We used the Leukocyte ImmunoTest™ (LIT™) to quantify neutrophil ROS release using a small volume (10 µL) of capillary blood in a portable, rapid (10-min) format. Results: ROS values (LIT score) and ROS levels assessed in relation to neutrophil count (LIT/N) were both markedly elevated in the patient group. Furthermore, these correlated strongly with peripheral neutrophil count and CRP value. Serial measurement of neutrophil or CRP values were not able to reliably predict mortality within the study. In contrast, LIT and LIT/N values started to decline at 7 and 5 days, respectively, in patients who survived ICU admission and this increment increased further thereafter. Conclusions: This study raises the possibility of LIT and LIT/N to be used as a predictive clinical tool for patients with severe COVID-19 and argues for its assessment to inform on prognosis, and potentially guide treatment pathways, in other disorders associated with neutrophil activation. Take-home message: A longitudinal study of 44 severe COVID-19 patients in the ICU of a leading teaching hospital has demonstrated the prognostic potential of a rapid bedside assay of neutrophil-derived reactive oxygen species (ROS). Assessment of changes in ROS production, as measured using the Leukocyte ImmunoTest™, shows that ROS production generally declined back to normal levels for patients who survived, but remained elevated for those patients who did not survive.
- 6 October 2023
- Published by Springer Nature in Intensive Care Medicine Experimental
- Vol. 11 (1) , 1-12
Open AccessAssessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases
Purpose: A prompt and effective immune response is required for clearance of pathogens but exaggerated states of inflammation can cause extensive collateral damage to the host. We have previously used a rapid near-patient assay that measures the functional capacity of neutrophils to produce reactive oxygen species (ROS) to show that values are elevated in patients with severe COVID-19 or sepsis. Here, we assess the utility of longitudinal ROS measurements to monitor and predict mortality outcome for patients with COVID-19 infection being treated in an ICU setting. Methods: We used the Leukocyte ImmunoTest™ (LIT™) to quantify neutrophil ROS release using a small volume (10 µL) of capillary blood in a portable, rapid (10-min) format. Results: ROS values (LIT score) and ROS levels assessed in relation to neutrophil count (LIT/N) were both markedly elevated in the patient group. Furthermore, these correlated strongly with peripheral neutrophil count and CRP value. Serial measurement of neutrophil or CRP values were not able to reliably predict mortality within the study. In contrast, LIT and LIT/N values started to decline at 7 and 5 days, respectively, in patients who survived ICU admission and this increment increased further thereafter. Conclusions: This study raises the possibility of LIT and LIT/N to be used as a predictive clinical tool for patients with severe COVID-19 and argues for its assessment to inform on prognosis, and potentially guide treatment pathways, in other disorders associated with neutrophil activation. Take-home message: A longitudinal study of 44 severe COVID-19 patients in the ICU of a leading teaching hospital has demonstrated the prognostic potential of a rapid bedside assay of neutrophil-derived reactive oxygen species (ROS). Assessment of changes in ROS production, as measured using the Leukocyte ImmunoTest™, shows that ROS production generally declined back to normal levels for patients who survived, but remained elevated for those patients who did not survive.
- Open Access
- 21 February 2022
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 2 (1) , e30
Evaluation of prevalance and risk factors for bloodstream infection in severe coronavirus disease 2019 (COVID-19) patients
Objectives: In this study, we sought to determine the prevalence of bloodstream infection (BSI) in severe coronavirus disease 2019 (COVID-19) patients and to determine the risk factors of BSI in critical COVID-19 patients. Design: Retrospective, descriptive study between March 2020 and January 2021. Setting: An 1,007-bed university hospital. Participants: Patients who were hospitalized due to severe COVID-19 disease and had an aerobic blood culture taken at least once during hospitalization Methods: Case definitions were made according to National Institutes of Health clinical definitions. According to the blood culture results, the patients were grouped as with and without BSIs, and compared for BSIs risk factors. Results: In total, 195 patients were included in the study. Blood culture positivity was detected in 76 (39.0%) of 196 patients. Excluding blood culture positivity considered as contamination, the prevalence of BSI in all severe COVID-19 cases was 18.5% (n = 36). In intensive care unit patients the prevalence of BSI was 30.6% (n = 26). In multivariate analyses, central venous catheter (odds ratio [OR], 8.17; 95% confidence interval [CI], 2.46–27.1; P < .01) and hospitalization in the multibed intensive care unit (OR, 4.28; 95% CI, 1.28–14.3; P < .01) were risk factors associated with the acquisition of BSI. Conclusion: The prevalence of BSI in COVID-19 patients is particularly high in critically ill patients. The central venous catheter and multibed intensive care follow-up are risk factors for BSI. BSIs can be reduced by increasing compliance to infection control measures and central venous catheter insertion-care procedures. The use of single-bed intensive care units where compliance can be achieved more effectively is important for the prevention of BSIs.
- 21 February 2022
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 2 (1) , e30
Open AccessEvaluation of prevalance and risk factors for bloodstream infection in severe coronavirus disease 2019 (COVID-19) patients
Objectives: In this study, we sought to determine the prevalence of bloodstream infection (BSI) in severe coronavirus disease 2019 (COVID-19) patients and to determine the risk factors of BSI in critical COVID-19 patients. Design: Retrospective, descriptive study between March 2020 and January 2021. Setting: An 1,007-bed university hospital. Participants: Patients who were hospitalized due to severe COVID-19 disease and had an aerobic blood culture taken at least once during hospitalization Methods: Case definitions were made according to National Institutes of Health clinical definitions. According to the blood culture results, the patients were grouped as with and without BSIs, and compared for BSIs risk factors. Results: In total, 195 patients were included in the study. Blood culture positivity was detected in 76 (39.0%) of 196 patients. Excluding blood culture positivity considered as contamination, the prevalence of BSI in all severe COVID-19 cases was 18.5% (n = 36). In intensive care unit patients the prevalence of BSI was 30.6% (n = 26). In multivariate analyses, central venous catheter (odds ratio [OR], 8.17; 95% confidence interval [CI], 2.46–27.1; P < .01) and hospitalization in the multibed intensive care unit (OR, 4.28; 95% CI, 1.28–14.3; P < .01) were risk factors associated with the acquisition of BSI. Conclusion: The prevalence of BSI in COVID-19 patients is particularly high in critically ill patients. The central venous catheter and multibed intensive care follow-up are risk factors for BSI. BSIs can be reduced by increasing compliance to infection control measures and central venous catheter insertion-care procedures. The use of single-bed intensive care units where compliance can be achieved more effectively is important for the prevention of BSIs.
- Open Access
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 2095-2100
Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
Background/aim: The aim of the study was to investigate whether treating haematological malignancy (HM) patients in a separate intensive care unit (ICU) would reduce ICU mortality. Materials and methods: HM patients treated by the same ICU team in a general medical ICU (GM-ICU) and a separate haematology ICU (H-ICU) were included in this study. Patients' demographic characteristics and ICU data were recorded retrospectively. Differences in the ICU course and prognosis between these two groups were determined. Results: A total of 251 patients (102 from GM-ICU, 149 from H-ICU) were included in this study. The disease severity and organ failure scores at ICU admission and underlying HMs were not different between the two groups. Patients waited longer for admission to GM ICU. Therapeutic procedures were performed significantly more frequently in GM-ICU. ICU complications were not different between the groups. ICU mortality rates were higher in GM-ICU (59.8% vs 37.6%, p = 0.006). Conclusion: A separate ICU allocated for haematology patients will allow timely and rapid admission of HM patients to ICU. Thus, mortality rates of HM patients needing ICU care will decline.
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 2095-2100
Open AccessCan treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
Background/aim: The aim of the study was to investigate whether treating haematological malignancy (HM) patients in a separate intensive care unit (ICU) would reduce ICU mortality. Materials and methods: HM patients treated by the same ICU team in a general medical ICU (GM-ICU) and a separate haematology ICU (H-ICU) were included in this study. Patients' demographic characteristics and ICU data were recorded retrospectively. Differences in the ICU course and prognosis between these two groups were determined. Results: A total of 251 patients (102 from GM-ICU, 149 from H-ICU) were included in this study. The disease severity and organ failure scores at ICU admission and underlying HMs were not different between the two groups. Patients waited longer for admission to GM ICU. Therapeutic procedures were performed significantly more frequently in GM-ICU. ICU complications were not different between the groups. ICU mortality rates were higher in GM-ICU (59.8% vs 37.6%, p = 0.006). Conclusion: A separate ICU allocated for haematology patients will allow timely and rapid admission of HM patients to ICU. Thus, mortality rates of HM patients needing ICU care will decline.
- 30 December 2020
- Published by Tip Egitimi Dunyasi in Tıp Eğitimi Dünyası
- Vol. 19 (59) , 46-52
Evaluation of Compliance of the Case-Based Multistation Electronic Internal Medicine Exam with National Core Curriculum-2014
Aim: Clinical reasoning is described as a mental process that occurs when a doctor encounter with patient in clinical environment. Clinical reasoning contains anamnesis, diagnosis, and management. Cases have been used both to teach and assess clinical reasoning. Core curriculum should be considered in the selection process of cases. The aim of this study is to evaluate the compliance with the National Core Curriculum-2014 of the questions of the case-based multistation electronic exam, which is carried out at the end of Internal Diseases internship, that is for assessing clinical reasoning skill of the Year-6 medical students in Gazi University Faculty of Medicine.Methods: The study was conducted between May-December 2019 with 289 Year-6 medical students at the end of Internal Medicine internship period. Questions of the case-based multistation electronic exam were prepared by Internist faculty members. In total, 5 exams were carried out using SocrativeTM to give immediate feedback. Every exam consisted of 3 cases. End of all the exams, questions of cases were categorized in the classes of anamnesis, physical examination, pre-diagnosis, laboratory findings, treatment. Compliance with the National Core Curriculum-2014 was evaluated.Results: In total, 14 cases and 74 questions nested in cases were evaluated. 26 (35.1%) of the questions were about laboratory findings. 16 (21.6%) of the questions were under treatment class. In 13 (92.8%) of the cases, there was at least a question expects higher levels than National Core Curriculum-2014. Out of 74 questions, 31 (41.8%) of them assessed higher levels than National Core Curriculum-2014. Mean scores of the students were significantly lower at questions that assess higher levels than National Core Curriculum-2014 (p<0.05).Conclusion: Faculty members do not take into consideration National Core Curriculum-2014. This poses a serious threat since assessment drives learning. Faculty development on National Core Curriculum and assessment could be a solution.
- 30 December 2020
- Published by Tip Egitimi Dunyasi in Tıp Eğitimi Dünyası
- Vol. 19 (59) , 46-52
Evaluation of Compliance of the Case-Based Multistation Electronic Internal Medicine Exam with National Core Curriculum-2014
Aim: Clinical reasoning is described as a mental process that occurs when a doctor encounter with patient in clinical environment. Clinical reasoning contains anamnesis, diagnosis, and management. Cases have been used both to teach and assess clinical reasoning. Core curriculum should be considered in the selection process of cases. The aim of this study is to evaluate the compliance with the National Core Curriculum-2014 of the questions of the case-based multistation electronic exam, which is carried out at the end of Internal Diseases internship, that is for assessing clinical reasoning skill of the Year-6 medical students in Gazi University Faculty of Medicine.Methods: The study was conducted between May-December 2019 with 289 Year-6 medical students at the end of Internal Medicine internship period. Questions of the case-based multistation electronic exam were prepared by Internist faculty members. In total, 5 exams were carried out using SocrativeTM to give immediate feedback. Every exam consisted of 3 cases. End of all the exams, questions of cases were categorized in the classes of anamnesis, physical examination, pre-diagnosis, laboratory findings, treatment. Compliance with the National Core Curriculum-2014 was evaluated.Results: In total, 14 cases and 74 questions nested in cases were evaluated. 26 (35.1%) of the questions were about laboratory findings. 16 (21.6%) of the questions were under treatment class. In 13 (92.8%) of the cases, there was at least a question expects higher levels than National Core Curriculum-2014. Out of 74 questions, 31 (41.8%) of them assessed higher levels than National Core Curriculum-2014. Mean scores of the students were significantly lower at questions that assess higher levels than National Core Curriculum-2014 (p<0.05).Conclusion: Faculty members do not take into consideration National Core Curriculum-2014. This poses a serious threat since assessment drives learning. Faculty development on National Core Curriculum and assessment could be a solution.
- Open Access
- 17 December 2020
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 50 (8) , 1810-1816
The factors predicting pneumonia in COVID-19 patients: preliminary results from a university hospital in Turkey
Pneumonia is the most serious clinical presentation of COVID-19. This study aimed to determine the demographic, clinical, and laboratory findings that can properly predict COVID-19 pneumonia. This study was conducted in the Gazi University hospital. All hospitalized patients with confirmed and suspected SARS-CoV-2 infection between 16 March 2020 and 30 April 2020 were analyzed retrospectively. COVID-19 patients were separated into two groups, pneumonia and nonpneumonia, and then compared to determine predicting factors for COVID-19 pneumonia. Variables that had a P-value of less than 0.20 and were not correlated with each other were included in the logistic regression model. Of the 247 patients included in the study 58% were female, and the median age was 40. COVID-19 was confirmed in 70.9% of these patients. Among the confirmed COVID-19 cases, 21.4% had pneumonia. In the multivariate analysis male sex (P = 0.028), hypertension (P = 0.022), and shortness of breath on hospital admission (P = 0.025) were significant factors predicting COVID-19 pneumonia. Shortness of breath, male sex, and hypertension were significant for predicting COVID-19 pneumonia on admission. Patients with these factors should be evaluated more carefully for diagnostic procedures, such as thorax CT.
- 17 December 2020
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 50 (8) , 1810-1816
Open AccessThe factors predicting pneumonia in COVID-19 patients: preliminary results from a university hospital in Turkey
Pneumonia is the most serious clinical presentation of COVID-19. This study aimed to determine the demographic, clinical, and laboratory findings that can properly predict COVID-19 pneumonia. This study was conducted in the Gazi University hospital. All hospitalized patients with confirmed and suspected SARS-CoV-2 infection between 16 March 2020 and 30 April 2020 were analyzed retrospectively. COVID-19 patients were separated into two groups, pneumonia and nonpneumonia, and then compared to determine predicting factors for COVID-19 pneumonia. Variables that had a P-value of less than 0.20 and were not correlated with each other were included in the logistic regression model. Of the 247 patients included in the study 58% were female, and the median age was 40. COVID-19 was confirmed in 70.9% of these patients. Among the confirmed COVID-19 cases, 21.4% had pneumonia. In the multivariate analysis male sex (P = 0.028), hypertension (P = 0.022), and shortness of breath on hospital admission (P = 0.025) were significant factors predicting COVID-19 pneumonia. Shortness of breath, male sex, and hypertension were significant for predicting COVID-19 pneumonia on admission. Patients with these factors should be evaluated more carefully for diagnostic procedures, such as thorax CT.